The U.S. FDA has approved Viberzi (eluxadoline) and Xifaxan (rifaximin), two new treatments for irritable bowel syndrome with diarrhea in adults.
GI & Endoscopy
Here are the five most popular GI/endoscopy stories on Becker's ASC Review for the week of May 25 to May 29.
Lovell Federal Health Care Center in North Chicago, Ill., has opened a new GI clinic, according to a Chicago Tribune report.
Bergein F. Overholt, MD, FACP, MACG, is a gastroenterologist practicing with Gastrointestinal Associates in Knoxville, Tenn. He also serves as medical director of the Laser Department of the Thompson Cancer Survival Center in Knoxville. He is a founding member and…
Here are 13 gastroenterologists and colorectal surgeons who were featured in the news within the past week.
Three gastroenterologists share the most exciting things they learned or experienced at Digestive Disease Week this year.
Yvette Tache, PhD, has received the 2014 Middleton Award for her research on peripheral autonomic pathways influencing GI function.
Anu K. Mathew, MD, has received the Compassionate Doctor Award from Vitals.
M. Bishr Omary, MD, PhD, is chair of the department of molecular and integrative physiology, professor of internal medicine and the H. Marvin Pollard Professor of Gastroenterology at the University of Michigan in Ann Arbor. . He previously served as…
GERD experts weighed in on their experiences using Stretta Therapy to treat patients suffering from GERD during a presentation at Digestive Disease Week 2015.
